|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.7150 NOK | -4.67% |
|
-12.27% | -48.19% |
| Jun. 30 | Exact Therapeutics to Delist from Euronext Growth Oslo in October | MT |
| Jun. 26 | EXACT Therapeutics AS Gets Positive Safety Review For 60 ?l/Kg Dose In Phase 2 ENACT Trial | RE |
| Market Cap | 47.45M 4.83M 4.23M 3.89M 3.62M 6.87M 461M 6.96M 46.62M 18.15M 226M 18.13M 17.74M 784M | P/E 2024 |
-2.49x | P/E 2025 | -1x |
|---|---|---|---|---|---|
| Enterprise Value | 23.54M 2.4M 2.1M 1.93M 1.79M 3.41M 228M 3.45M 23.13M 9M 112M 8.99M 8.8M 389M | EV / Sales 2024 |
-
| EV / Sales 2025 | 1,074,437,000x |
| Free-Float |
30.97% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.67% | ||
| 1 week | -12.27% | ||
| Current month | -12.27% | ||
| 1 month | -14.88% | ||
| 3 months | -57.69% | ||
| 6 months | -52.33% | ||
| Current year | -48.19% |
| 1 week | 0.67 |  | 0.88 |
| 1 month | 0.58 | | 0.93 |
| Current year | 0.58 | | 2.7 |
| 1 year | 0.58 | | 3 |
| 3 years | 0.58 | | 20 |
| 5 years | 0.58 | | 24.8 |
| 10 years | 0.58 | | 53.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
Svein Kvåle
COO | Chief Operating Officer | - | 2011-12-31 |
Per Walday
CEO | Chief Executive Officer | 66 | 2022-06-05 |
John Edminson
DFI | Director of Finance/CFO | - | 2022-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | - | |
Leiv Askvig
BRD | Director/Board Member | 69 | - |
| Chairman | 55 | 2018-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-01-03 | Buy | Chairman | 2,500 | 0.0083% | ||
| 23-01-03 | Buy | Chief Financial Officer | 2,500 | 0.0083% | ||
| 23-01-03 | Buy | Chief Executive Officer | 2,500 | 0.0083% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.67% | -12.27% | -74.65% | -93.78% | 4.83M | |
| -0.09% | +6.05% | +3.73% | +10.25% | 50.25B | |
| -0.66% | +0.03% | +410.89% | +609.91% | 40.39B | |
| +0.66% | +6.75% | +26.97% | -4.86% | 34.38B | |
| -1.24% | +7.37% | +26.96% | +61.41% | 34.4B | |
| -4.19% | -1.84% | +3.76% | +32.17% | 26.32B | |
| +0.57% | +0.85% | - | - | 16.64B | |
| -2.28% | +2.89% | +70.87% | +131.35% | 16.14B | |
| +1.11% | +1.31% | +15.23% | +22.42% | 13.71B | |
| +1.71% | +5.69% | +100.59% | +100.59% | 13.75B | |
| Average | -0.94% | +2.64% | +64.93% | +96.61% | 24.6B | |
| Weighted average by Cap. | -0.63% | +4.06% | +93.62% | +138.45% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 0.06 0.01 0.01 0 0 0.01 0.57 0.01 0.06 0.02 0.28 0.02 0.02 0.97 |
| Net income | -52.33M -5.33M -4.66M -4.3M -3.99M -7.57M -508M -7.67M -51.42M -20.01M -249M -20M -19.56M -865M | -86.97M -8.85M -7.75M -7.14M -6.63M -12.58M -844M -12.75M -85.46M -33.26M -414M -33.24M -32.51M -1.44B |
| Net Debt | -98.89M -10.06M -8.81M -8.12M -7.54M -14.31M -960M -14.5M -97.17M -37.82M -471M -37.79M -36.96M -1.63B | -23.91M -2.43M -2.13M -1.96M -1.82M -3.46M -232M -3.51M -23.5M -9.14M -114M -9.14M -8.94M -395M |
Employees
11
Calendar
Sep. 02 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-07 | NOK 0.7150 | -4.67% | 48,675 |
| 26-07-06 | NOK 0.7500 | +4.17% | 32,645 |
| 26-07-03 | NOK 0.7200 | -4.00% | 9,022 |
| 26-07-02 | NOK 0.7500 | -5.66% | 44,800 |
| 26-07-01 | NOK 0.7950 | -2.45% | 14,783 |
- Stock Market
- Stocks
- EXTX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
